Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation

Biochemical and Biophysical Research Communications

Volumn 316, Issue 2, 2004, Pages 533-539

  Carlson, Christian J ^a   White, Morris F ^b   Rondinone, Cristina M ^a  

^a ABBOTT LABORATORIES   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

3T3 L1 adipocytes; c Jun NH2 terminal kinase; Cellular localization; Insulin; Okadaic acid; PP2A; Signal transduction

Indexed keywords

AMINO ACID; ANISOMYCIN; ENZYME INHIBITOR; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; OKADAIC ACID; PHOSPHATASE; PROTEIN KINASE B; RAPAMYCIN; SERINE; STRESS ACTIVATED PROTEIN KINASE; TARGET OF RAPAMYCIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; DRUG EFFECT; ENZYME ACTIVATION; MAMMAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADIPOCYTES; AMINO ACIDS; ANIMALS; ANISOMYCIN; CELL LINE; CYTOSOL; ENZYME INHIBITORS; INSULIN; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; SERINE; SIGNAL TRANSDUCTION; SIROLIMUS;

MAMMALIA;

EID: 1542616960     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.02.082     Document Type: Article

References (33)

1. White M.F. The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Recent Prog. Horm. Res. 53:1998;119-138.
2. Sun X.J., Rothenberg P., Kahn C.R., Backer J.M., Araki E., Wilden P.A., Cahill D.A., Goldstein B.J., White M.F. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature. 352:1991;73-77.
3. Paz K., Liu Y.-F., Shorer H., Hemi R., LeRoith D., Quan M., Kanety H., Seger R., Zick Y. Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulated IRS-1 function. J. Biol. Chem. 274:1999;28816-28822.
4. Greene M.W., Garofalo R.S. Positive and negative regulatory role of insulin receptor substrate 1 and 2 (IRS-1 and IRS-2) serine/threonine phosphorylation. Biochemisty. 41:2002;7082-7091.
5. Paz K., Hemi R., LeRoith D., Karasik A., Elhanany E., Kanety H., Zick Y. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J. Biol. Chem. 272:1997;29911-29918.
6. Tanti J.-F., Gremeaux T., Van Obberghen E., Marchand-Brustel Y.L. Insulin receptor substrate 1 is phosphorylated by the serine kinase activity of phosphatidylinositol 3-kinase. J. Biol. Chem. 269:1994;6051-6057.
7. Aguire V., Uchida T., Yenush L., Davis R., White M.F. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of ser(307). J. Biol. Chem. 275:2000;9047-9054.
8. Aguire V., Werner E.D., Giraud J., Lee Y.H., Shoelson S.E., White M.F. Phosphorylation of ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277:2002;1531-1537.
9. Greene M.W., Sakaue H., Wang L., Alessi D.R., Roth R.A. Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by serine 312 phosphorylation. J. Biol. Chem. 278:2003;8199-8211.
10. Gual P., Gonzalez T., Gremeaux T., Barres T., Le Marchand-Brustel Y., Tanti J.F. Hyperosmotic stress inhibits insulin receptor substrate-1 function by distinct mechanisms in 3T3-L1 adipocytes. J. Biol. Chem. 278:2003;26550- 26557.
11. Rui L., Agguire V., Kim J.K., Shulman G.I., Lee A., Corbould A., Dunaif A., White M.F. Insulin/IGF-1 and TNF-α stimulate phosphorylation of IRS-1 at inhibitory ser307 via distinct pathways. J. Clin. Invest. 107:2001;181-189.
12. Yu C., Chen Y., Zong H., Wang Y., Bergeron R., Kim J.K., Cline G.W., Cushman S.W., Clooney G.J., Atcheson B., White M.F., Kraegan E.W., Shulman G.I. Mechanism by which fatty acid inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277:2002;50230-50236.
13. Gao Z., Zuberi A., Quon M.J., Dong Z., Ye J. Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases. J. Biol. Chem. 278:2003;24944-24950.
14. Jiang G., Dallas-Yang Q., Liu F., Moller D.E., Zhang B.B. Salicylic acid reverses phorbol 12-myristate- 13-acetate (PMA)- and tumor necrosis factor alpha (TNFα)-induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance inhuman embryonic kidney 293 (HEK293) cells. J. Biol. Chem. 278:2003;180-186.
15. Sun X.J., Goldberg J.L., Qiao L.-Y., Mitchell J.J. Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes. 48:1999;1359-1364.
16. Pederson T.M., Kramer D.L., Rondinone C.M. Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation. Diabetes. 50:2001;24-31.
17. Berg C.E., Lavan B.E., Rondinone C.M. Rapamycin partially prevents insulin resistance induced by chronic insulin treatment. Biochem. Biophys. Res. Commun. 293:2002;1021-1027.
18. Gual P., Gremeaux T., Gonzalez T., Le Marchand-Brustel Y., Tanti J.-F. MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612, and 632. Diabetologia. 46:2003;1532-1542.
19. Pham P.-T.T., Heydrick S.J., Fox H.L., Kimball S.R., Jefferson L.S. Jr., Lynch C.J. Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes. J. Cell. Biochem. 79:2000;427-441.
20. Heller-Harrison R.A., Morin M., Czech M.P. Insulin regulation of membrane-associated insulin receptor substrate 1. J. Biol. Chem. 270:1995;24442-24450.
21. Burnett P.E., Barrow R.K., Cohen N.A., Snyder S.H., Sabatini D.M. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl. Acad. Sci. USA. 95:1998;1432-1437.
22. Scott P.H., Brunn G.J., Kohn A.D., Roth R.A., Lawrence J.C. Jr. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc. Natl. Acad. Sci. USA. 95:1998;7772-7777.
23. Nave B.T., Ouwens D.M., Withers D.J., Alessi D.R., Shepherd P.R. Mammalian target of rapamycin is a direct target for protein kinase b: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J. 344:1999;427-431.
24. Peterson R.T., Desai B.N., Hardwick J.S., Schreiber S.L. Protein phosphatase 2A interacts with the 70-kDa s6 kinase and is activated by inhibition of FKBP12-rapamycin associated protein. Proc. Natl. Acad. Sci. USA. 96:1999;4438-4442.
25. Clark S.F., Molero J.-C., James D.E. Release of insulin receptor substrate proteins from an intracellular complex coincides with the development of insulin resistance. J. Biol. Chem. 275:2000;3819-3826.
26. Takano A., Usui I., Haruta T., Kawahara J., Uno T., Iwata M., Kobayashi M. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin. Mol. Cell. Biol. 21:2001;5050-5062.
27. McMahon L.P., Choi K.M., Lin T.-A., Abraham R.T., Lawrence J.C. Jr. The rapamycin binding domain governs substrate selectivity by the mammalian target of rapamycin. Mol. Cell. Biol. 22:2002;7428-7438.
28. Widman C., Gibson S., Jarpe M.B., Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Phyiol. Rev. 79:1999;143-180.
29. Gao Z., Hwang D., Bataille F., Lefevre M., York D., Quon M.J., Ye J. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa b kinase complex. J. Biol. Chem. 277:2002;48115-48121.
30. Lee Y.H., Giraud J., Davis R.J., White M.F. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J. Biol. Chem. 278:2003;2896-2902.
31. Ozes O.N., Akca H., Mayo L.D., Gustin J.A., Maehama T., Dixon J.E., Donner D.B. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc. Natl. Acad. Sci. USA. 98:2001;4640-4645.
32. Hartley D., Cooper G.M. Role of mTOR in the degradation of IRS-1: regulation of PP2A activity. J. Cell. Biochem. 85:2002;304-314.
33. Resjo S., Goransson O., Harndahl L., Zolnierowics S., Manganiello V., Degerman E. Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes. Cell. Signal. 14:2002;231-238.